A phase III open label study to evaluate safety and efficacy of Boceprevir-response guided therapy in controlled HIV patients with chronic hepatitis C genotype 1 infection who failed previously to Peginterferon /ribavirin.

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2013
This article has no abstract
Epistemonikos ID: 799e9506632aab69e015a96eb6fbd85610e32906
First added on: Jan 22, 2025